|
CN111166733A
|
|
Resveratrol-fatty acid coupling compound and medical application thereof
|
|
CN109422725A
|
|
Drugs for prostate cancer
|
|
CN109134568A
|
|
Nucleotide phosphate/amide derivatives and its medical usage
|
|
CN108530484A
|
|
Liver-targeted anti-HBV drug
|
|
CN108129514A
|
|
The individual isomer and its medical usage of phosphoric acid/phosphonate derivative
|
|
CN107556324A
|
|
Deuterated anti-hepatitis C virus reactive compound
|
|
CN107540679A
|
|
Anti- hepatitis C virus compound and its medical usage
|
|
CN106474478A
|
|
Replace the pharmaceutical composition of Buddhist nun according to Shandong
|
|
CN110156838A
|
|
Phosphoric acid/phosphonate derivative and its medical usage
|
|
CN103804417A
|
|
Anti-hepatitis B virus drug
|
|
CN103508981A
|
|
New piperazine derivative and medical applications
|
|
CN102050815A
|
|
Dabigatran ester derivatives as prodrug
|
|
CN101987198A
|
|
Medicinal composition
|
|
CN101880239A
|
|
Water-soluble amino-acid ester derivative of propofol
|
|
CN101880286A
|
|
Water-soluble amino-acid ester derivative of ginkgolide B
|
|
CN103012336A
|
|
Water-soluble amino-acid ester derivative of andrographolide and dehydroandrographolide
|
|
CN101104078A
|
|
Polypeptide and protein medicine polyethylene coupling compound
|
|
CN1827634A
|
|
Nitrate derivatives of glycyrrhetic acid and glycyrrhetinic acid and pharmaceutical use thereof
|
|
CN1827627A
|
|
Novel acyclic nucleoside phosphonic acid and its ester derivatives and pharmaceutical use thereof
|
